A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
